2017
DOI: 10.1136/archdischild-2017-313887
|View full text |Cite
|
Sign up to set email alerts
|

HPV vaccination rate in French adolescent girls: an example of vaccine distrust

Abstract: It is imperative to improve the distribution of credible information about vaccination, unbiased and scientifically supported by a strong institutional position and to rethink the place of the clinician in the system of adolescent health and disease prevention in France.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
16
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(18 citation statements)
references
References 22 publications
(10 reference statements)
1
16
0
1
Order By: Relevance
“…The vaccine was not re-instated in schools, and public concerns remain, despite evidence that there is no link to multiple sclerosis (Langer-Gould et al, 2014). There have also been concerns about the efficacy and safety of the HPV vaccine (possibly partly caused by the authorities' rapid approval of the vaccine which surprised GPs and preceded the distribution of information about HPV (Lefèvre et al, 2017)), and especially around the influenza A(H1N1) (swine flu) vaccine. In 2009 there was a heated controversy over the cost of the government's large influenza vaccination campaign, the lack of transparency in the purchasing of the vaccines, perceived alarmist communication by public health authorities, conflicts of interest on the part of some MoH advisers, and the safety of the vaccine .…”
Section: Article Historymentioning
confidence: 99%
“…The vaccine was not re-instated in schools, and public concerns remain, despite evidence that there is no link to multiple sclerosis (Langer-Gould et al, 2014). There have also been concerns about the efficacy and safety of the HPV vaccine (possibly partly caused by the authorities' rapid approval of the vaccine which surprised GPs and preceded the distribution of information about HPV (Lefèvre et al, 2017)), and especially around the influenza A(H1N1) (swine flu) vaccine. In 2009 there was a heated controversy over the cost of the government's large influenza vaccination campaign, the lack of transparency in the purchasing of the vaccines, perceived alarmist communication by public health authorities, conflicts of interest on the part of some MoH advisers, and the safety of the vaccine .…”
Section: Article Historymentioning
confidence: 99%
“…Vaccination rates against many vaccine-preventable diseases are considerably low in adults (8)(9)(10). For example, 50000-70000 adults die of vaccine-preventable diseases in United States of America every year (11).…”
Section: Introductionmentioning
confidence: 99%
“…Internationally, aside from efficacy and safety concerns, barriers towards HPV vaccination [17] have been cost, practicality issues, lack of trust in healthcare providers and authorities, and social norms [17], [18], [19], [20], [21]. Many of these factors depend on information sources, and while this has been previously explored in the general population [22], it has been previously underexplored in mothers, which is of interest as they are often the primary health care decision makers in families [23], [24], [25].…”
Section: Introductionmentioning
confidence: 99%